ArticleCureus2024
Ketamine Impact on Kidney Health.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ketamine-induced uropathy (KIU) is a serious consequence of chronic ketamine abuse, presenting with complex renal and urinary symptoms. This study describes a 34-year-old female with a history of chronic ketamine abuse, resulting in stage 3 chronic kidney disease (CKD) and severe urological complications. Despite discontinuing ketamine use five years ago, she remains dependent on ureteral stents due to recurrent hydronephrosis and ureteral obstruction. The patient began using ketamine at the age of 25 years, consuming approximately 5 g daily for two years. By the age of 27 years, she developed dysuria, flank pain, and burning micturition and was later diagnosed with ketamine-associated cystitis and renal failure secondary to hydronephrosis. Initially, bilateral ureteral stents were placed to manage her condition, but she continued to experience worsening symptoms. Although studies suggest that early cessation of ketamine can resolve ulcerative cystitis and ureteral obstruction, this was not observed in our patient. This case highlights the importance of high suspicion for ketamine abuse in young patients presenting with ureteral complications such as hydronephrosis and cystitis-like symptoms. It highlights the need for early detection, ongoing follow-up, and a comprehensive approach involving pharmacological and surgical interventions. Effective management also requires counseling on ketamine discontinuation to prevent further and permanent damage to the urinary system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.